PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Jayson Punwani will moderate a panel at the 2nd annual Kenan-Flagler Business School Health Care conference on financing innovation.
News | 10. 29. 2012
Jayson Punwani will moderate a panel at the 2nd annual Kenan-Flagler Business School Health Care conference on financing innovation.
